Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
A healthy pregnant woman translates to a healthy baby. It's the reason why many women go to great lengths to improve their health once they become pregnant.
But as Toronto General Hospital Research Institute scientist Dr.
Lena Serghides has discovered in a two recent studies, women who are infected with the human immunodeficiency virus (HIV) face greater challenges when trying to ensure their baby's health.
HIV-positive pregnant women are advised to take a drug regimen – commonly referred to as combination antiretroviral therapy (cART) – to prevent mother-to-child transmission of the virus. Unfortunately, these antiretroviral regimens are often associated with a number of adverse birth outcomes, including preterm delivery and low birth weight.
To examine the effects of these treatments, Dr. Serghides and her team measured the levels of several different hormones in pregnant women, before and after they were randomly assigned to take two different cART regimens.
The team found that levels of the hormone, estradiol, were decreased with one type of cART regimen and increased with the other. These changes were linked to significantly lower birth weight, suggesting that hormonal changes may contribute to the cART-associated fetal growth restriction.
"The cART regimens that were used both prevent the virus from replicating, but target the virus through different mechanisms," says Dr. Serghides. "The results of our study underscore the need for more research on the long-term effects of these regimens as they may affect fetal development by differentially altering hormone levels."
This work was supported by the Canadian Institutes of Health Research, the Ontario HIV Treatment Network G655, the Canadian Foundation for AIDS Research, the Global Alliance to Prevent Prematurity and Stillbirth and Grand Challenges in Global Health: Preventing Preterm Birth Initiative. KC Kain holds a Tier 1 Canada Research Chair in Molecular Parasitology.
Read more about the work of Dr. Serghides in the